Visit
Breaking Updates in Hematological-Oncology
The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.
Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.
Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.
ASH 2020
#TXMPN22 | @harrisoncn1 discusses novel targets and combinations being explored in MPNs:
👉http://ow.ly/70he50KOSG1👈
#MPNsm #HemOnc #BloodCancerAwarenessMonth
First session tomorrow! (How time flies…..) https://twitter.com/lymphoma_soph/status/1573994220594941957
Are you a registrar looking to learn the evidence base for the diagnosis & management of #lymphoma? Or a consultant/nurse looking for an update to your knowledge around research & practice? #LymphomaManagement Course is for you! > http://lymphoma-action.org.uk/LymphomaManagement @graham74GC @tobyeyre82
We spoke to @anniencowan (@DanaFarber) at #IMS2022, who shared some updates from the PROMISE study, which is screening high-risk individuals for precursor conditions such as MGUS and MGIP:
🎥: http://ow.ly/ibfm50KOSf3
@Myeloma_Society #MMsm #HemOnc #BloodCancerAwarenessMonth
We're pleased to bring you another podcast! 🤩
Join experts Heinz Ludwig & Meral Beksac, who discuss the importance of identifying high-risk myeloma & future therapeutic strategies for this patient population.
🎧: http://ow.ly/2Top50KQC0l
#MMsm #HemOnc #ImmunoOnc
ASH 2020
Breaking Updates in Hematological-Oncology
The American Society of Hematology (ASH) 2020 Annual Meeting and Exposition was held on the 5–8 December.
Despite the pandemic, the virtual format showcased outstanding leaps in understanding and treatment in 2020, across malignancies.
Explore our coverage by disease type, including updates from key trials in which new agents are moving forwards.
#TXMPN22 | @harrisoncn1 discusses novel targets and combinations being explored in MPNs:
👉http://ow.ly/70he50KOSG1👈
#MPNsm #HemOnc #BloodCancerAwarenessMonth
First session tomorrow! (How time flies…..) https://twitter.com/lymphoma_soph/status/1573994220594941957
Are you a registrar looking to learn the evidence base for the diagnosis & management of #lymphoma? Or a consultant/nurse looking for an update to your knowledge around research & practice? #LymphomaManagement Course is for you! > http://lymphoma-action.org.uk/LymphomaManagement @graham74GC @tobyeyre82
We spoke to @anniencowan (@DanaFarber) at #IMS2022, who shared some updates from the PROMISE study, which is screening high-risk individuals for precursor conditions such as MGUS and MGIP:
🎥: http://ow.ly/ibfm50KOSf3
@Myeloma_Society #MMsm #HemOnc #BloodCancerAwarenessMonth
We're pleased to bring you another podcast! 🤩
Join experts Heinz Ludwig & Meral Beksac, who discuss the importance of identifying high-risk myeloma & future therapeutic strategies for this patient population.
🎧: http://ow.ly/2Top50KQC0l
#MMsm #HemOnc #ImmunoOnc
VJHemOnc is intended for Healthcare Professionals onlyBy choosing to continue, you are confirming that you are a healthcare professional
Sign-up for our Newsletter!
Keep up to date with all the latest news with our monthly newsletter
